Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C22H28Cl2O4 |
Molecular Weight | 427.361 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]3(Cl)[C@@]2([H])CCC4=CC(=O)C=C[C@]34C
InChI
InChIKey=QLIIKPVHVRXHRI-CXSFZGCWSA-N
InChI=1S/C22H28Cl2O4/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,24)17(26)10-20(16,3)22(12,28)18(27)11-23/h6-7,9,12,15-17,26,28H,4-5,8,10-11H2,1-3H3/t12-,15+,16+,17+,19+,20+,21+,22+/m1/s1
Molecular Formula | C22H28Cl2O4 |
Molecular Weight | 427.361 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:45:26 UTC 2023
by
admin
on
Fri Dec 15 15:45:26 UTC 2023
|
Record UNII |
8HR4QJ6DW8
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
CFR |
21 CFR 524.957
Created by
admin on Fri Dec 15 15:45:26 UTC 2023 , Edited by admin on Fri Dec 15 15:45:26 UTC 2023
|
||
|
NDF-RT |
N0000175450
Created by
admin on Fri Dec 15 15:45:26 UTC 2023 , Edited by admin on Fri Dec 15 15:45:26 UTC 2023
|
||
|
WHO-VATC |
QR03BA07
Created by
admin on Fri Dec 15 15:45:26 UTC 2023 , Edited by admin on Fri Dec 15 15:45:26 UTC 2023
|
||
|
WHO-ATC |
D07AC13
Created by
admin on Fri Dec 15 15:45:26 UTC 2023 , Edited by admin on Fri Dec 15 15:45:26 UTC 2023
|
||
|
WHO-ATC |
R03AK09
Created by
admin on Fri Dec 15 15:45:26 UTC 2023 , Edited by admin on Fri Dec 15 15:45:26 UTC 2023
|
||
|
NCI_THESAURUS |
C211
Created by
admin on Fri Dec 15 15:45:26 UTC 2023 , Edited by admin on Fri Dec 15 15:45:26 UTC 2023
|
||
|
WHO-VATC |
QR01AD09
Created by
admin on Fri Dec 15 15:45:26 UTC 2023 , Edited by admin on Fri Dec 15 15:45:26 UTC 2023
|
||
|
WHO-ATC |
R01AD09
Created by
admin on Fri Dec 15 15:45:26 UTC 2023 , Edited by admin on Fri Dec 15 15:45:26 UTC 2023
|
||
|
WHO-VATC |
QS02CA91
Created by
admin on Fri Dec 15 15:45:26 UTC 2023 , Edited by admin on Fri Dec 15 15:45:26 UTC 2023
|
||
|
WHO-VATC |
QR03AK09
Created by
admin on Fri Dec 15 15:45:26 UTC 2023 , Edited by admin on Fri Dec 15 15:45:26 UTC 2023
|
||
|
WHO-VATC |
QD07AC13
Created by
admin on Fri Dec 15 15:45:26 UTC 2023 , Edited by admin on Fri Dec 15 15:45:26 UTC 2023
|
||
|
NDF-RT |
N0000175576
Created by
admin on Fri Dec 15 15:45:26 UTC 2023 , Edited by admin on Fri Dec 15 15:45:26 UTC 2023
|
||
|
WHO-ATC |
R03BA07
Created by
admin on Fri Dec 15 15:45:26 UTC 2023 , Edited by admin on Fri Dec 15 15:45:26 UTC 2023
|
||
|
WHO-ATC |
D07XC03
Created by
admin on Fri Dec 15 15:45:26 UTC 2023 , Edited by admin on Fri Dec 15 15:45:26 UTC 2023
|
||
|
CFR |
21 CFR 524.1044H
Created by
admin on Fri Dec 15 15:45:26 UTC 2023 , Edited by admin on Fri Dec 15 15:45:26 UTC 2023
|
||
|
WHO-VATC |
QD07XC03
Created by
admin on Fri Dec 15 15:45:26 UTC 2023 , Edited by admin on Fri Dec 15 15:45:26 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C053915
Created by
admin on Fri Dec 15 15:45:26 UTC 2023 , Edited by admin on Fri Dec 15 15:45:26 UTC 2023
|
PRIMARY | |||
|
8HR4QJ6DW8
Created by
admin on Fri Dec 15 15:45:26 UTC 2023 , Edited by admin on Fri Dec 15 15:45:26 UTC 2023
|
PRIMARY | |||
|
6970
Created by
admin on Fri Dec 15 15:45:26 UTC 2023 , Edited by admin on Fri Dec 15 15:45:26 UTC 2023
|
PRIMARY | |||
|
6030
Created by
admin on Fri Dec 15 15:45:26 UTC 2023 , Edited by admin on Fri Dec 15 15:45:26 UTC 2023
|
PRIMARY | |||
|
C66181
Created by
admin on Fri Dec 15 15:45:26 UTC 2023 , Edited by admin on Fri Dec 15 15:45:26 UTC 2023
|
PRIMARY | |||
|
8HR4QJ6DW8
Created by
admin on Fri Dec 15 15:45:26 UTC 2023 , Edited by admin on Fri Dec 15 15:45:26 UTC 2023
|
PRIMARY | |||
|
Mometasone, Nasal
Created by
admin on Fri Dec 15 15:45:26 UTC 2023 , Edited by admin on Fri Dec 15 15:45:26 UTC 2023
|
PRIMARY | |||
|
441335
Created by
admin on Fri Dec 15 15:45:26 UTC 2023 , Edited by admin on Fri Dec 15 15:45:26 UTC 2023
|
PRIMARY | |||
|
108118
Created by
admin on Fri Dec 15 15:45:26 UTC 2023 , Edited by admin on Fri Dec 15 15:45:26 UTC 2023
|
PRIMARY | RxNorm | ||
|
DB00764
Created by
admin on Fri Dec 15 15:45:26 UTC 2023 , Edited by admin on Fri Dec 15 15:45:26 UTC 2023
|
PRIMARY | |||
|
105102-22-5
Created by
admin on Fri Dec 15 15:45:26 UTC 2023 , Edited by admin on Fri Dec 15 15:45:26 UTC 2023
|
PRIMARY | |||
|
DTXSID10872412
Created by
admin on Fri Dec 15 15:45:26 UTC 2023 , Edited by admin on Fri Dec 15 15:45:26 UTC 2023
|
PRIMARY | |||
|
CHEMBL1161
Created by
admin on Fri Dec 15 15:45:26 UTC 2023 , Edited by admin on Fri Dec 15 15:45:26 UTC 2023
|
PRIMARY | |||
|
SUB09045MIG
Created by
admin on Fri Dec 15 15:45:26 UTC 2023 , Edited by admin on Fri Dec 15 15:45:26 UTC 2023
|
PRIMARY | |||
|
100000080358
Created by
admin on Fri Dec 15 15:45:26 UTC 2023 , Edited by admin on Fri Dec 15 15:45:26 UTC 2023
|
PRIMARY | |||
|
MOMETASONE
Created by
admin on Fri Dec 15 15:45:26 UTC 2023 , Edited by admin on Fri Dec 15 15:45:26 UTC 2023
|
PRIMARY | |||
|
Mometasone, Topical
Created by
admin on Fri Dec 15 15:45:26 UTC 2023 , Edited by admin on Fri Dec 15 15:45:26 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
BINDER->LIGAND |
BINDING
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Volume of Distribution | PHARMACOKINETIC |
|
|
|||
Biological Half-life | PHARMACOKINETIC |
|
|
|||